Brian Adams - Jun 7, 2021 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role: General Counsel
Signature: /s/ Brian Adams
Stock symbol: RLAY
Transactions as of: Jun 7, 2021
Transactions value $: -$200,720
Form type: 4
Date filed: 6/9/2021, 08:37 PM
Next filing: Jun 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RLAY	Common Stock	Options Exercise	$26.8K	+6.5K	+25.13%	$4.12	32.4K	Jun 7, 2021	Direct	F1
transaction	RLAY	Common Stock	Sale	-$228K	-6.5K	-20.08%	$35.00	25.9K	Jun 7, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RLAY	Stock Option (Right to Buy)	Options Exercise	$0	-6.5K	-4.06%	$0.00	154K	Jun 7, 2021	Common Stock	6.5K	$4.12	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020.
F2	Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.